Primary |
Sedation |
30.8% |
Anaesthesia |
20.1% |
Product Used For Unknown Indication |
7.0% |
General Anaesthesia |
4.9% |
Induction Of Anaesthesia |
4.2% |
Status Epilepticus |
4.0% |
Sedative Therapy |
3.8% |
Colonoscopy |
3.7% |
Local Anaesthesia |
3.5% |
Premedication |
2.8% |
Rabies |
2.6% |
Convulsion |
1.9% |
Surgery |
1.7% |
Analgesia |
1.6% |
Analgesic Therapy |
1.6% |
Endoscopy |
1.6% |
Endotracheal Intubation |
1.4% |
Hypertension |
1.0% |
Agitation |
0.9% |
Anaesthetic Premedication |
0.9% |
|
Drug Ineffective |
33.8% |
Vomiting |
7.1% |
Sedation |
6.7% |
Anaphylactic Reaction |
5.3% |
Unresponsive To Stimuli |
4.4% |
Urticaria |
4.4% |
Convulsion |
4.0% |
Product Quality Issue |
4.0% |
Tachycardia |
3.6% |
Respiratory Arrest |
3.1% |
Somnolence |
3.1% |
Drug Effect Decreased |
2.7% |
Hypotension |
2.7% |
Medication Error |
2.7% |
Pharmaceutical Product Complaint |
2.2% |
Respiratory Depression |
2.2% |
Swelling |
2.2% |
Tonic Convulsion |
2.2% |
Drug Interaction |
1.8% |
Metabolic Acidosis |
1.8% |
|
Secondary |
Drug Use For Unknown Indication |
20.3% |
Product Used For Unknown Indication |
17.9% |
Anaesthesia |
13.6% |
Sedation |
10.7% |
General Anaesthesia |
4.5% |
Pain |
3.9% |
Hypertension |
3.8% |
Induction Of Anaesthesia |
3.8% |
Premedication |
3.3% |
Convulsion |
2.7% |
Status Epilepticus |
2.3% |
Sedative Therapy |
2.0% |
Ill-defined Disorder |
1.8% |
Epilepsy |
1.7% |
Infection |
1.5% |
Electrolyte Substitution Therapy |
1.3% |
Constipation |
1.3% |
Prophylaxis |
1.3% |
Pyrexia |
1.2% |
Anxiety |
1.2% |
|
Drug Ineffective |
9.9% |
Toxic Epidermal Necrolysis |
9.0% |
Rhabdomyolysis |
8.4% |
Unresponsive To Stimuli |
6.5% |
Drug Rash With Eosinophilia And Systemic Symptoms |
6.2% |
Hypotension |
5.9% |
Tachycardia |
5.6% |
Anaphylactic Shock |
5.3% |
Urticaria |
5.3% |
Vomiting |
4.3% |
Myoclonus |
4.0% |
Intentional Drug Misuse |
3.7% |
Stevens-johnson Syndrome |
3.7% |
Anaphylactic Reaction |
3.4% |
Pyrexia |
3.4% |
Cardiac Arrest |
3.1% |
Overdose |
3.1% |
Pulmonary Embolism |
3.1% |
Renal Failure |
3.1% |
Respiratory Failure |
3.1% |
|
Concomitant |
Drug Use For Unknown Indication |
34.6% |
Product Used For Unknown Indication |
23.9% |
Sedation |
5.9% |
Anaesthesia |
5.3% |
Prophylaxis |
4.2% |
Pain |
3.2% |
Infection |
2.5% |
Hypertension |
2.4% |
Induction Of Anaesthesia |
2.2% |
Fluid Replacement |
2.0% |
Pneumonia |
1.7% |
Constipation |
1.6% |
Premedication |
1.4% |
Coronary Artery Bypass |
1.4% |
Diffuse Large B-cell Lymphoma |
1.4% |
General Anaesthesia |
1.3% |
Pyrexia |
1.3% |
Maintenance Of Anaesthesia |
1.3% |
Nausea |
1.3% |
Nutritional Support |
1.2% |
|
Vomiting |
11.4% |
Sepsis |
7.3% |
Renal Failure |
6.7% |
Respiratory Failure |
6.4% |
Pain |
6.1% |
Thrombocytopenia |
5.8% |
Ventricular Tachycardia |
5.3% |
Serotonin Syndrome |
4.9% |
Tachycardia |
4.7% |
Unresponsive To Stimuli |
4.6% |
Septic Shock |
4.4% |
Multi-organ Failure |
4.0% |
Rhabdomyolysis |
3.9% |
Ventricular Fibrillation |
3.9% |
Unevaluable Event |
3.7% |
Anxiety |
3.6% |
Injury |
3.4% |
Renal Failure Acute |
3.4% |
Pyrexia |
3.3% |
Weight Increased |
3.3% |
|
Interacting |
Product Used For Unknown Indication |
37.0% |
Subarachnoid Haemorrhage |
10.4% |
Anaesthesia |
9.6% |
Hypertension |
4.4% |
Induction Of Anaesthesia |
4.4% |
Restless Legs Syndrome |
4.4% |
Sedation |
4.4% |
Maintenance Of Anaesthesia |
3.0% |
Sepsis |
3.0% |
Thrombosis Prophylaxis |
3.0% |
Blood Pressure Fluctuation |
2.2% |
Hiv Infection |
2.2% |
Anaesthetic Premedication |
1.5% |
Arginase Increased |
1.5% |
Epilepsy |
1.5% |
Hypotension |
1.5% |
Intubation |
1.5% |
Myocardial Infarction |
1.5% |
Polysubstance Dependence |
1.5% |
Pulmonary Sepsis |
1.5% |
|
Drug Interaction |
17.4% |
Disorientation |
8.7% |
Extensor Plantar Response |
8.7% |
Hypotension |
8.7% |
Infectious Peritonitis |
8.7% |
Pseudocroup |
8.7% |
Amnesia |
4.3% |
Asphyxia |
4.3% |
Cardiac Arrest |
4.3% |
Coma |
4.3% |
Overdose |
4.3% |
Respiratory Arrest |
4.3% |
Respiratory Depression |
4.3% |
Sinus Arrest |
4.3% |
Tenotomy |
4.3% |
|